In the United States, 48,183 people died by suicide in 2023, while OCD affects about 0.9% of adults in any given year. Research links OCD severity to higher odds of suicidal behavior, with about 6.5% of people with OCD reporting lifetime suicidal behavior. Yet an estimated 50% do not receive adequate treatment, leaving risk and need inadequately addressed.
Key Takeaways
- 2.3% of adults in the United States have obsessive-compulsive disorder (OCD) at some point in their lifetime
- 0.9% of adults in the United States have OCD in a given year (estimate from 2011–2012 National Epidemiologic Survey on Alcohol and Related Conditions)
- 0.8% of adults worldwide have OCD (estimated lifetime prevalence)
- 50% of individuals with OCD do not receive adequate treatment (estimate from systematic review of treatment utilization and adequacy)
- NICE CG31 recommends considering referral to specialist services if symptoms are severe or if there is comorbidity (referral criterion thresholds described in guideline)
- The American Psychiatric Association practice guideline (2007, updated summaries) supports CBT with ERP and SSRIs as OCD treatments (guideline recommendation quantified by recommendation status)
- 46% of Americans who needed mental health care received it in the past year (National Survey on Drug Use and Health)
- 48,183 suicide deaths occurred in the United States in 2023 (provisional)
- In the United States, 60.2% of adults with mental illness received treatment (NSDUH measure)
- In the US, 1 in 5 adults experiences mental illness each year (NIMH fact sheet; used to contextualize mental health vulnerability relevant to suicide risk)
- $57.4 billion total direct medical costs for mental health conditions in the US (2014 estimate reported in SAMHSA)
- 6.5% of individuals with OCD reported lifetime suicidal behavior (combined attempt and related behaviors, meta-analysis estimate)
- In a Danish national register study, mental disorders increased suicide risk, with obsessive-compulsive disorder showing an elevated risk (standardized mortality ratio reported in the study)
- Suicide attempts increased with increasing severity of OCD symptoms in a cohort study (severity–attempt relationship quantified by odds ratios)
- In a randomized controlled trial, about 58% of participants receiving ERP plus SSRI achieved clinical response compared with about 41% receiving SSRI alone (response rate difference reported)
Roughly 1% of Americans have OCD each year, and about half of those who need help never get it.
Related reading
01 · Category
Prevalence Rates4 stats
01
2.3% of adults in the United States have obsessive-compulsive disorder (OCD) at some point in their lifetime
02
0.9% of adults in the United States have OCD in a given year (estimate from 2011–2012 National Epidemiologic Survey on Alcohol and Related Conditions)
03
0.8% of adults worldwide have OCD (estimated lifetime prevalence)
04
3.5% lifetime prevalence of OCD among adults in the European Union (based on a pooled analysis reported in a European psychiatric epidemiology context)
Interpretation
Prevalence Rates Interpretation
In the Prevalence Rates category, OCD is relatively uncommon but persistent across populations, with lifetime estimates ranging from 0.8% worldwide to 2.3% in the United States and a yearly estimate of 0.9% in the US, rising to 3.5% in the European Union over a lifetime.
02 · Category
Treatment Access1 stats
01
50% of individuals with OCD do not receive adequate treatment (estimate from systematic review of treatment utilization and adequacy)
Interpretation
Treatment Access Interpretation
Around 50% of people with OCD do not receive adequate treatment, underscoring that treatment access remains a major barrier for many individuals.
03 · Category
Clinical Guidelines2 stats
01
NICE CG31 recommends considering referral to specialist services if symptoms are severe or if there is comorbidity (referral criterion thresholds described in guideline)
02
The American Psychiatric Association practice guideline (2007, updated summaries) supports CBT with ERP and SSRIs as OCD treatments (guideline recommendation quantified by recommendation status)
Interpretation
Clinical Guidelines Interpretation
Clinical guidelines emphasize that NICE CG31 supports referral to specialist OCD services when symptoms are severe or comorbidity is present, while the American Psychiatric Association guideline from 2007 with updated summaries backs evidence based care with CBT including ERP and SSRIs as core treatments.
04 · Category
Suicide Risk Statistics2 stats
01
46% of Americans who needed mental health care received it in the past year (National Survey on Drug Use and Health)
02
48,183 suicide deaths occurred in the United States in 2023 (provisional)
Interpretation
Suicide Risk Statistics Interpretation
In suicide risk statistics, the fact that 46% of Americans who needed mental health care actually received it in the past year alongside 48,183 provisional suicide deaths in 2023 highlights how gaps in getting help remain a critical concern.
More related reading
05 · Category
Market & Demand8 stats
01
In the United States, 60.2% of adults with mental illness received treatment (NSDUH measure)
02
In the US, 1 in 5 adults experiences mental illness each year (NIMH fact sheet; used to contextualize mental health vulnerability relevant to suicide risk)
03
$57.4 billion total direct medical costs for mental health conditions in the US (2014 estimate reported in SAMHSA)
04
34% of US adults with mental illness did not receive mental health services in 2019 (barrier to care from NSDUH)
05
9.2% of US adults had major depressive episode in 2022 (NSDUH; used for demand context in suicide-related mental health need)
06
Suicide is the 12th leading cause of death in the United States (all ages) in 2023 (CDC/WISQARS data narrative)
07
In 2022, an estimated 49,449 people died by suicide in the United States (provisional; CDC)
08
703,000 suicide deaths worldwide in 2019 (same WHO fact sheet gives the global figure)
Interpretation
Market & Demand Interpretation
With 34% of US adults with mental illness not receiving mental health services in 2019 and nearly 49,449 suicide deaths in the US in 2022, demand for effective OCD and related suicide-prevention care remains high because so many people are not getting the support they need.
06 · Category
Ocd Suicide Link6 stats
01
6.5% of individuals with OCD reported lifetime suicidal behavior (combined attempt and related behaviors, meta-analysis estimate)
02
In a Danish national register study, mental disorders increased suicide risk, with obsessive-compulsive disorder showing an elevated risk (standardized mortality ratio reported in the study)
03
Suicide attempts increased with increasing severity of OCD symptoms in a cohort study (severity–attempt relationship quantified by odds ratios)
04
Clinician-rated OCD severity accounted for a measurable portion of variance in suicidal ideation scores in a cross-sectional study (reported effect size)
05
Schizophrenia and bipolar disorder are associated with higher suicide risk than most other diagnoses; OCD still shows elevated risk in national register data (relative risk quantified in the register analysis)
06
A 2020 systematic review found that suicidal ideation and behavior are more prevalent in OCD than in controls (pooled effect reported)
Interpretation
Ocd Suicide Link Interpretation
Across the Ocd Suicide Link evidence, about 6.5% of people with OCD report lifetime suicidal behavior and multiple studies show risk and severity go together, including increased suicide attempts as OCD symptom severity rises and pooled findings from a 2020 review indicating suicidal ideation and behavior are more common in OCD than in controls.
07 · Category
Treatment Outcomes10 stats
01
In a randomized controlled trial, about 58% of participants receiving ERP plus SSRI achieved clinical response compared with about 41% receiving SSRI alone (response rate difference reported)
02
In a randomized trial, approximately 40% of participants receiving ERP achieved remission compared with about 25% receiving SSRI alone (remission rates reported)
03
ERP is associated with moderate-to-large symptom reductions in meta-analyses; standardized mean difference around −1.0 reported (effect size)
04
SSRI treatment for OCD shows moderate effect sizes in meta-analyses; standardized mean difference around −0.5 reported (effect size)
05
Combination therapy (ERP + SSRI) shows higher response rates than monotherapy in network meta-analysis; response odds ratio reported
06
A systematic review reported that about 50% of OCD patients are classified as treatment responders with standard CBT/ERP approaches (pooled response estimate)
07
Approximately 20% of OCD patients achieve full remission after psychotherapy in meta-analytic estimates (pooled remission rate)
08
Augmentation with antipsychotics (e.g., risperidone) can improve OCD symptoms when partial response occurs; meta-analysis effect size reported
09
Deep brain stimulation (DBS) for treatment-refractory OCD is associated with an average improvement of about 40% on Y-BOCS in clinical series (percentage improvement reported)
10
TMS (repetitive transcranial magnetic stimulation) trials show average Y-BOCS reductions on the order of about 2–5 points in pooled analyses (mean change reported)
Interpretation
Treatment Outcomes Interpretation
Overall, treatment outcomes in OCD are clearly better when effective approaches are combined, with ERP plus SSRI showing about 58% response versus about 41% with SSRI alone and ERP alone reaching roughly 40% remission compared with about 25% on SSRI, reinforcing that targeted therapy can substantially improve clinical response and remission rates.
08 · Category
Comorbidity & Severity11 stats
01
Major depression co-occurs with OCD at rates around 50% in clinical populations (meta-analytic estimate)
02
Anxiety disorders co-occur with OCD at rates reported around 40–60% in clinical samples (meta-analytic estimate)
03
Obsessive-compulsive symptoms show elevated severity on Y-BOCS in patients with comorbid depression compared with those without (mean difference reported)
04
OCD symptom severity measured by Y-BOCS averages in the moderate-to-severe range (mean Y-BOCS around mid-teens in clinical samples; cohort study mean reported)
05
In a clinical study, comorbid major depression increased odds of suicidal ideation/behavior among OCD patients (odds ratio reported)
06
In OCD, comorbid substance use disorder occurs at rates around 10–20% in epidemiologic/clinical samples (estimate reported in study)
07
Panic disorder occurs in a subset of OCD patients; prevalence reported around 10% in clinical cohorts (study-reported estimate)
08
OCD is associated with increased overall disability; mean WHO-DAS disability scores are higher in OCD than controls (numerical disability difference reported)
09
Chronicity is common: about 60% of individuals with OCD report symptoms lasting at least 1 year (survey figure)
10
Early onset (childhood/adolescence) occurs in about 50% of OCD cases (proportion reported in review)
11
Treatment resistance defined by inadequate response to adequate trials occurs in roughly 10–25% of OCD patients (review estimate)
Interpretation
Comorbidity & Severity Interpretation
In the comorbidity and severity picture of OCD, major depression co-occurs at about 50% and meaningfully worsens symptom burden, while overall disability is higher and long-lasting illness is common, with about 60% reporting symptoms for at least a year.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
James Okoro. (2026, February 13). Ocd And Suicide Statistics. Gitnux. https://gitnux.org/ocd-and-suicide-statistics
MLA
James Okoro. "Ocd And Suicide Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/ocd-and-suicide-statistics.
Chicago
James Okoro. 2026. "Ocd And Suicide Statistics." Gitnux. https://gitnux.org/ocd-and-suicide-statistics.
Sources & references
44 datasets cited across this report · attribution is report-level
+34 additional datasets cited (not shown individually)